Top Biotech News (2 July 2025)

Virtual Cells Transform Biology

Summary:

AI-powered virtual cells could revolutionise biology, shifting from 90% experimental to 90% computational work, though critics cite hype over concrete results.

Amgen’s Cancer Drug Success

Summary:

Bemarituzumab combined with chemotherapy significantly improved survival in gastric cancer patients, despite eye-related side effects in Phase III trial.

Scientific Academy Under Siege

Summary:

Trump administration cuts force US National Academies into crisis, with budget slashes, staff layoffs, and censorship accusations over diversity research bans.

AbbVie’s £2.1bn Cell Therapy Bet

Summary:

AbbVie acquires Capstan Therapeutics for up to $2.1bn, gaining access to revolutionary in-vivo CAR-T technology using lipid nanoparticles and mRNA.

Peer Review Gets Democratic Makeover

Summary:

Distributed peer review trials show promise, cutting funding decisions from months to weeks whilst democratising reviews, though expertise concerns remain.

Subscribe to the latest updates in the newsletter

Share your disease area, therapeutic candidate and research objectives.

Related Solutions

Organoid Service
Research Service
Technical Service

ODISEI CNS - Human brain & retinal organoid
solutions for translational CNS discovery.

Please provide the information below, and our team will contact you shortly with brochure and relevant case studies.

Thank you for your submission.

Our team has received your request and will get back to you shortly.
If you do not receive our confirmation email, kindly check your spam or junk folder.